Health
INVEST Pitch Perfect Spotlight: How One Startup Aims To Become the Leading Medicaid Mental Health Provider for Kids
Healthy Young Minds is an online youth mental health startup. It was recently crowned winner of MedCity News’ INVEST Pitch Perfect contest focused...
13 Pitfalls That Spell Doom for Google Ad Conversions & How to Fix Them
Managing successful Google Ads campaigns is more than just winning clicks—it’s about converting those clicks into results (e.g., new patients or B2B inquiries)....
Cluster Headaches: Battling the Unseen Beast
Step into the unpleasant reality of cluster headaches and the silent battle many undergo, with the hope of a cure.
Experts Warn of Strong Link Between Alcohol and Six Types of Cancer
A recent report underscores a significant link between excessive alcohol consumption and the risk of six types of cancer, including breast, colorectal and...
Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD
Dupixent, a Sanofi and Regeneron Pharmaceuticals drug, is now approved for chronic obstructive pulmonary disease (COPD), a progressive lung disease prevalent in smokers....
Spinal Stenosis Treatment in India
You will need spinal stenosis treatment in India if you want relief from your back pain. Back pain is common in people with...
Links
Tyler Cowen on the price of Ozempic. Problems with the OMB’s social welfare function. Link between alcohol and cancer. Disparities in the rural-urban...
AI Holds Promise, But Concerns Around Costs and Data Remain
The new generation of healthcare AI innovation is promising, but there are some problems that remain when it comes to AI, such as...
FDA Approval of Bristol Myers Drug Makes It the First Novel Schizophrenia Med in Decades
Bristol Myers Squibb’s Cobenfy treats schizophrenia by going after a different target than currently available antipsychotic drugs, which is intended to offer better...
Over-the-Counter Oral Contraceptive Pills
Oral contraceptives are the most commonly used method of reversible contraception in the U.S. In July 2023, the FDA approved Opill, the first...